Further re Aivlosin

LAWRENCE plc (Lawrence)

                            Drug Registration Update


Following  the  announcement on May 17th 2004, Eco  Animal  Health  Ltd.  (ECO),
Lawrence's animal medications subsidiary, confirms that the CVMP (Committee  for
Veterinary  Medicinal  Products) has, in accordance with its  stated  timetable,
confirmed   and  circularised  its  positive  opinion  to  grant   a   marketing
authorisation for AIVLOSIN (macrolide antibiotic) for use in swine pneumonia  to
all  member  states.   ECO expects to be marketing AIVLOSIN  in  Europe  in  the
autumn.  As  previously  stated, further registrations for  AIVLOSIN  for  other
indications  and  use  in  different species are being  submitted  to  the  EMEA
(European Agency for the Evaluation of Medicinal Products) and we shall  provide
updates on their progress as appropriate.
*************************************************************

                        CREST PAPERLESS SETTLEMENT SYSTEM

Application  has  been  made  today for all of the  issued  Ordinary  Shares  in
Lawrence  plc to be eligible for admission to CREST which will take effect  from
22 July 2004. Accordingly, settlement of transactions in Ordinary Shares from 22
July 2004 may take place in CREST.

                                   **********